Outcomes of the endoscopic transsphenoidal surgery for resection of pituitary adenomas utilizing extracapsular dissection technique with a cotton swab

Purpose: The purpose of this study was to determine the effectiveness and safety of a cotton swab for extracapsular dissection in endoscopic transsphenoidal surgery (ETSS) for pituitary adenoma (PA). Materials and Methods: A retrospective review of patients undergoing ETSS for PA from 2014 to 2017 was undertaken. Only patients with extracapsular dissection by cotton swab with the intent to completely remove the tumor were included. Assessment of the prospectively recorded clinical, laboratory, and radiographic presentation as well as the intra- and postoperative data was carried out. Factors influencing the extent of resection were analyzed. Results: Of the 222 patients, one hundred cases met the inclusion criteria. The cohort consisted of 81 nonfunctioning and 19 functioning PAs. Fifty patients presented with visual disturbance and 34 patients had prior surgical treatment. The majority of PAs was macroadenoma (97%) with 73% modified Hardy Stage C and 38% Knosp Grade 4. Intraoperative cerebrospinal fluid (CSF) leakage was the most frequently noted complication (78%). Meningitis occurred in three cases and repeat ETSS for CSF leakage repair was necessary in three patients. No death or vascular injury was observed. At 12 months after ETSS, magnetic resonance imaging scan confirmed 43% complete tumor resection. Previous surgery and Knosp Grade 4 were the strong factors for incomplete PA removal by multivariate logistic regression analysis. For functioning PAs, thirteen patients (68.42%) achieved biochemical remission. Conclusion: Cotton swab for extracapsular dissection proved its clinical effectiveness and safety. In spite of the technique, negative predictors for complete PA resection were parasellar extension and previous surgery.

Key-words:

Cotton swab - endoscopic - extracapsular dissection - pituitary adenoma - transsphenoidal surgery

Introduction

Endoscopic transsphenoidal surgery (ETSS) for pituitary adenoma (PA) is one of the most commonly performed procedures in neurosurgery. With gross total PA resection set as the preferred goal, extracapsular dissection is encouraged to identify a tissue plane or cleavage between tumor's pseudocapsule and normal pituitary gland, arachnoid, or diaphragma sellae. Gentle separation of this plane ought to yield complete PA removal while lowering complication rates. Prevedello et al. reported, in 2013, the extracapsular dissection technique using a cotton swab.[[1]] Although it appeared intriguing, clinical outcome by this particular technique does not exist. The primary objective was, first, to evaluate the effectiveness and safety of this technique. The secondary aim was to analyze factors associated with the extent of tumor resection by ETSS.

Materials and Methods

Patient population

The prospectively maintained data of consecutive patients undergoing ETSS for PA from January 2014 to December 2017, performed by the senior author (AH), was reviewed. Only cases with pathology-confirmed PA were included. Each patient's preoperative demographics and clinical presentation were classified based on visual disturbance, endocrinological condition, and prior treatment for PA or asymptomatic presentation.

Surgical technique

All patients underwent ETSS, through binostril access, with the operating surgeons standing on their right side. Surgical technique, for the nasal, sphenoidal, and sellar phases, was similar to the previously narrated steps in our earlier publication.[[2]] Switching from curettage for PA removal, the senior author (AH) utilized cotton swab since 2014, as described by Prevedello et al.,[[1]] for extracapsular dissection [[Figure 1]]. The intraoperative data, including suspected or definite residual PA, and complication(s) were recorded. For cerebrospinal fluid (CSF) leakage, grading was based on Esposito et al.[[3]] The method for sellar defect repair, depending on CSF leak grade, was similar to our previous literature.[[2]] Although the cotton swab technique was undertaken in all of the cases, patients who had internal debulking only without circumferential pseudocapsule resection, as their intended surgical goal, were excluded from our analysis.

Figure 1: Endoscopic image shows utilizing a cotton swab for extracapsular dissection. The plane between overlying arachnoid and the pseudocapsule (capsule) of the tumor (solid curve line) was established along with the plane separating tumor and the normal pituitary gland (dotted line)

Pre- and post-operative assessment

For patients with visual disturbance, their visual acuity (VA) and visual field (VF) were assessed using Snellen chart and automated Humphrey perimetry, respectively. The visual function would be examined again, using the same methods, after ETSS at 6-month interval. When compared to preoperative data, the VA and VF outcomes were classified into improved, stable, or worse.

Regarding endocrinological status, preoperative pituitary hormone panel was obtained in every patient. Each hormone was classified as hyperproduction (in functioning PAs), normal, or deficiency. After ETSS, the hormone profiles were examined during the hospital stay and again, at 3-month interval. Functioning PA was considered in remission when the current standard criteria were met after surgery.[[4]],[[5]],[[6]] Any new postoperative hormonal deficit, with or without postoperative hormone replacement therapy, was documented.

Preoperative radiographic, computerized tomography and/or magnetic resonance imaging (MRI) scan, features were grouped based on sphenoid pneumatization [[7]] and modified Hardy's classification.[[8]] For parasellar extension of the tumor, modified Knosp grading was applied to coronal view evaluation.[[9]] Enclosed (Knosp 0, 1, 2) versus invasive adenoma (Knosp 3, 4) were categorized. From MRI scan at 12-month after ETSS, complete resection versus residual tumor was determined. For PA volume, each patient's pre- and post-operative MRI scans were calculated by drawing of the region of interest with OsirixLite software (Pixmeo Sarl, Bernex, Switzerland). The percentage of tumor resection was obtained by the pre- minus postoperative volume and divided by preoperative volume.

Postoperative in-hospital complications, such as apoplexy or CSF leakage requiring surgical repair, were noted. After hospital discharge, included patients must have had at least 1 year of follow-up with postoperative MRI scan, endocrinological, and visual assessment. Numerical data would be presented as mean (standard deviation) or median (interquartile range) where appropriate. Utilizing STATA statistical software version 14.2 (StataCorp, College Station, Texas, USA), logistic regression analysis was applied to identify positive and negative predictors, for the extent of resection and CSF leakage, of ETSS. P < 0.05 was considered statistically significant.

Results

Of the 222 consecutive cases during the study period, forty patients with non-PA were excluded from our assessment. Another 72 patients had only internal debulking for decompression. Their surgeries were without the initial aim to completely remove the tumor due to the giant size of PA. Hence, those cases were not included. Ten other patients with inadequate data and/or follow-up were omitted, leaving 100 cases for our examination. The median follow-up time was 18.26 months (12.76, 35.16).

Patient demographics, clinical presentation, and preoperative radiographic features [[Table 1]]

Table 1: Patient demographics, clinical presentation and preoperative radiographic features (m=100)

The mean age of patients was 50.41 years old (13.96) with equal proportion of both genders. Among the 50 patients with visual disturbance, forty of them (80%) had abnormal VA, whereas 46 (92%) had VF defect. Eighty-one patients (81%) had nonfunctioning PA. Nineteen functioning PAs (19%) were eight growth hormone-producing, five adrenocorticotropic hormone-producing, four prolactinomas, and two mixed hormone-producing adenomas. There were eight patients (8%) who presented with pituitary apoplexy. The median duration of symptom, in these symptomatic patients, was 12 months (3.24). Nineteen cases (19%) were recurrent Pas, whereas 14 patients (14%) had residual tumors without notable enlargement. Of the 34 patients who underwent pituitary surgery before our ETSS, they had an average of one prior procedure (range 1–5 procedures). Three patients had radiation therapy after multiple surgeries. Roughly two-thirds of the cohort had at least one, or more, the axis of the preoperative hormonal deficit.

Most of the PAs were macroadenomas (97%) with the median preoperative volume of 5.35 ml (2.7, 10.15). The majority of tumors were sizeable, having 73% Hardy stage C and 85% invasive adenoma. There was no difference in right-sided (44%) versus left-sided (43%) position of the normal pituitary gland. Sellar-type sphenoid pneumatization was found in 73%.

Intraoperative findings and short-term complications [[Table 2]]

Table 2: Intraoperative data and complications (n=100)

During ETSS, definite residual PAs were observed in 56 patients. Six cases had suspected tumor remaining. There was no internal carotid artery injury, but the majority (78%) had intraoperative CSF leakage, with Grade 1 being the most common. For short-term complications, postoperative CSF leakage, requiring repeat endoscopic endonasal repair, occurred in one patient with Grade 2 and two patients with Grade 3 intraoperative leakage. Three patients developed meningitis (3%). One of the three ensued from postoperative CSF leakage, whereas the other two patients did not have postoperative leakage.

Logistic regression analysis of risk factors associated with intraoperative CSF leakage, shown in [[Table 3]], demonstrates that modified Hardy stage A was the only protective factor against intraoperative CSF leakage (P = 0.013). Although the increasing age of patients seemed to be influential from univariate analysis (P = 0.028), this factor almost reached statistical significance by multivariate assessment (P = 0.058). Other nonsignificant factors were gender, pre- or postoperative tumor volume, sphenoid pneumatization, modified Knosp grade, intraoperative residual tumor, and complete tumor removal.

Table 3: Factors for intraoperative cerebrospinal fluid leakage

As for postoperative CSF leakage requiring ETSS for repair and meningitis, grade 1 intraoperative CSF leakage was the only protective factor against these complications (P = 0.040) [[Table 4]]. Age, gender, pre- or postoperative tumor volume, sphenoid pneumatization, modified Hardy stage, Knosp grade, intraoperative residual tumor, and complete tumor removal were nonsignificant elements.

Table 4: Factors for postoperative cerebrospinal fluid leakage and meningitis

Postoperative long-term outcomes

Extent of resection

Comparing preoperative to 12-month postoperative MRI scans, 43 cases had total tumor removal, whereas 57 cases had residual PAs. For all ETSS, the median postoperative volume was 0.2 ml (0, 1.33). The mean percentage of tumor's volume removal was 83.87% (23.52).

From the logistic regression analysis, Knosp 4 (P = 0.007) and history of previous surgery (P < 0.001) were the strong negative factors, in multivariate evaluation, for achieving total tumor removal [[Table 5]]. Although preoperative tumor volume (P = 0.022) and nonfunctioning PA (P = 0.017) were negative factors in univariate evaluation, they did not reach a significant level by multivariate assessment. Other factors, such as age, gender, modified Hardy stage, or intraoperative CSF leakage, were insignificant.

Table 5: Factors associated with total tumor removal

Visual outcomes

From the 50 patients who presented with visual symptoms, after ETSS, VA improved in 72%, whereas 26% remained stable. VF defect improved in 69% and was unchanged in 29%. One patient, who had prior multiple surgeries and radiotherapy, suffered worsening of her VA and VF after ETSS. All six patients with preoperative ophthalmoplegia improved after surgery.

Hormonal outcomes

At the last follow-up (minimum of 1 year) post-ETSS, remission of functioning PAs was achieved in 13 of 19 patients (68.42%). The majority of patients (67%) had unchanged postoperative hormonal status while 11% incurred, one or more axis, new deficit.

Discussion

ETSS for PA is becoming the standard of care.[[10]],[[11]],[[12]],[[13]] When possible, extracapsular dissection should be implemented for effectiveness and safety. Prevedello et al. proposed the utilization of a cotton swab for this particular maneuver.[[1]] Abandoning the ring curettes for tumor resection that the senior author (AH) had employed since 2006,[[2]] the Prevedello's technique was adopted, for extracapsular dissection, from 2014 until present. Despite many years of the very publication, clinical data to support its value still does not exist. We believe this study is the first to report clinical and radiographic outcomes of the cotton swab technique.

Our results confirmed that cotton swab for extracapsular dissection of PA was effective as shown by the remission rate for functioning PA at 68.4%, comparable to previous reports.[[14]],[[15]],[[16]],[[17]],[[18]],[[19]] Regarding its safety, there was no life-threatening complication. One patient (2%) with prior extensive treatments did suffer worsening of her vision. Postoperative CSF leakage and meningitis were 3%. These rates were in line with previously reported series for postoperative CSF leakage at 1.4%–16.9%[[13]],[[20]],[[21]],[[22]],[[23]],[[24]] and meningitis at 0%–10%.[[3]],[[13]],[[23]]

Rather disappointing was the rate of complete tumor removal at 43%, below the reported range from literature at 62.4% to 90%.[[13]],[[20]],[[25]],[[26]],[[27]],[[28]],[[29]],[[30]],[[31]],[[32]] Yet, given our intraoperative observation of 62, combined definite and suspected, residual PAs, this was not unexpected. From the logistic regression analysis in [[Table 5]], Knosp 4 proved to be the negative factor for total PA removal. This concurred with our intraoperative finding that most of the remaining tumors were in the cavernous sinus. In addition, previous surgery was also an unfavorable factor for achieving total tumor removal, similarly to reports by others.[[13]],[[33]] This outcome might, indeed, reflect the fact that our cases were made up of large or postsurgical PAs as tertiary care center would have received from other hospitals. Another likely explanation, for the below-average total PA resection rate, could be that the senior author (AH) frequently exercised caution, by less aggressive tumor resection, for fear of higher grade CSF leakage. Thin pseudocapsules, with marked arachnoid adherence, were not removed in many older, unlike younger, patients for this very reason. The result from the logistic regression analysis in [[Table 3]] reiterated this bias from the surgeon. In addition, having mostly nonfunctioning PAs could have an impact for the less vigorous resection than those with functioning PAs. It could have potentially caused our lower rate of total tumor removal. This influence was also evident by univariate analysis in [[Table 5]].

Our study limitations are as followed. Despite prospectively collected data, the retrospective analysis yielded lower power of evidence. The second pitfall could be the high percentage of difficult PAs, i.e., previous surgery or invasive adenomas. They had a significant impact on the outcomes regardless of surgical technique. Moreover, the selection bias by the operating surgeon could have affected the total PA resection as aforementioned. In spite of some imperfect results, extracapsular dissection technique using a cotton swab proved its safety and effectiveness.

Conclusion

The outcomes of ETSS by cotton swab technique for extracapsular dissection demonstrated its effectiveness and safety. It should be increasingly utilized by more surgeons for widespread practice. Again, confirmed by our study, previous surgery and Knosp 4 were negative factors for achieving total tumor removal.

Conflict of Interest

There are no conflicts of interest.

Acknowledgment

The authors would like to thank Miss Suraida Aeesoa for assistance in the statistical analysis of the study.

Financial support and sponsorship

Nil.

• References

• 1 Prevedello DM, Ebner FH, de Lara D, Ditzel Filho L, Otto BA, Carrau RL. Extracapsular dissection technique with the cotton swab for pituitary adenomas through an endoscopic endonasal approach – How I do it. Acta Neurochir (Wien) 2013;155:1629-32.
• 2 Hansasuta A, Pokanan S, Punyawai P, Mahattanakul W. Evolution of technique in endoscopic transsphenoidal surgery for pituitary adenoma: A Single institution experience from 220 procedures. Cureus 2018;10:e2010.
• 3 Esposito F, Dusick JR, Fatemi N, Kelly DF. Graded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery. Oper Neurosurg (Hagerstown) 2007;60:295-303.
• 4 Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, et al. Treatment of Cushing's syndrome: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2015;100:2807-31.
• 5 Katznelson L, Laws ER Jr., Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014;99:3933-51.
• 6 Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(2):273-88.
• 7 Zwagerman NT, Lieber S, Fernandez-Miranda JC. Surgical anatomy of the sellar region. In: Laws ER Jr., Cohen-Gadol AA, Schwartz TH, Sheehan JP, editors. Transsphenoidal Surgery: Complication Avoidance and Management Techniques. Cham: Springer International Publishing; 2017. p. 145-65.
• 8 Wilson CB. Neurosurgical management of large and invasive pituitary tumors. In: Tindall GT, Collins WF, Editor. Clinical Management of Pituitary Disorders. New York: Raven Press; 1979. p. 335-42.
• 9 Micko AS, Wohrer A, Wolfsberger S, Knosp E. Invasion of the cavernous sinus space in pituitary adenomas: Endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 2015;122(4):803-11.
• 10 Kuo JS, Barkhoudarian G, Farrell CJ, Bodach ME, Tumialan LM, Oyesiku NM, et al. Congress of neurological surgeons systematic review and evidence-based guideline on surgical techniques and technologies for the management of patients with nonfunctioning pituitary adenomas. Neurosurgery 2016;79:E536-8.
• 11 Cho DY, Liau WR. Comparison of endonasal endoscopic surgery and sublabial microsurgery for prolactinomas. Surg Neurol 2002;58:371-5.
• 12 Jain AK, Gupta AK, Pathak A, Bhansali A, Bapuraj JR. Excision of pituitary adenomas: Randomized comparison of surgical modalities. Br J Neurosurg 2007;21:328-31.
• 13 Hansasuta A. Outcomes and complications of endoscopic transsphenoidal surgery for pituitary adenoma. In: Hansasuta A, editor. Endoscopic Transsphenoidal Surgery for Pituitary Adenoma. Bangkok: Moh-Chao-Ban Publishing House; 2018. p. 82-131.
• 14 Netuka D, Májovský M, Masopust V, Belšán T, Marek J, Kršek M, et al. Intraoperative magnetic resonance imaging during endoscopic transsphenoidal surgery of growth hormone-secreting pituitary adenomas. World Neurosurg 2016;91:490-6.
• 15 Kim JH, Hur KY, Lee JH, Lee JH, Se YB, Kim HI, et al. Outcome of endoscopic transsphenoidal surgery for acromegaly. World Neurosurg 2017;104:272-8.
• 16 Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, et al. Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria. World Neurosurg 2017;108:278-90.
• 17 Sarkar S, Rajaratnam S, Chacko G, Mani S, Hesargatta AS, Chacko AG. Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: Outcomes with Cushing's disease. Acta Neurochir (Wien) 2016;158:77-86.
• 18 Shin SS, Gardner PA, Ng J, Faraji AH, Agarwal N, Chivukula S, et al. Endoscopic endonasal approach for adrenocorticotropic hormone-secreting pituitary adenomas: Outcomes and analysis of remission rates and tumor biochemical activity with respect to tumor invasiveness. World Neurosurg 2017;102:651-80.e1.
• 19 Cebula H, Baussart B, Villa C, Assié G, Boulin A, Foubert L, et al. Efficacy of endoscopic endonasal transsphenoidal surgery for Cushing's disease in 230 patients with positive and negative MRI. Acta Neurochir (Wien) 2017;159:1227-36.
• 20 Paluzzi A, Fernandez-Miranda JC, Tonya Stefko S, Challinor S, Snyderman CH, Gardner PA. Endoscopic endonasal approach for pituitary adenomas: A series of 555 patients. Pituitary 2014;17:307-19.
• 21 Shikary T, Andaluz N, Meinzen-Derr J, Edwards C, Theodosopoulos P, Zimmer LA. Operative learning curve after transition to endoscopic transsphenoidal pituitary surgery. World Neurosurg 2017;102:608-12.
• 22 Wang YY, Kearney T, Gnanalingham KK. Low-grade CSF leaks in endoscopic trans-sphenoidal pituitary surgery: Efficacy of a simple and fully synthetic repair with a hydrogel sealant. Acta Neurochir (Wien) 2011;153:815-22.
• 23 Lobatto DJ, de Vries F, Zamanipoor Najafabadi AH, Pereira AM, Peul WC, Vliet Vlieland TP, et al. Preoperative risk factors for postoperative complications in endoscopic pituitary surgery: A systematic review. Pituitary 2018;21:84-97.
• 24 Gardner PA, Snyderman CH, Fernandez-Miranda JC, Wang EW. Closure methods following transsphenoidal surgery. In: Laws ER Jr., Cohen-Gadol AA, Schwartz TH, Sheehan JP, editors. Transsphenoidal Surgery: Complication Avoidance and Management Techniques. Cham: Springer International Publishing; 2017. p. 303-14.
• 25 Frank G, Pasquini E, Farneti G, Mazzatenta D, Sciarretta V, Grasso V, et al. The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology 2006;83:240-8.
• 26 Dehdashti AR, Ganna A, Karabatsou K, Gentili F. Pure endoscopic endonasal approach for pituitary adenomas: Early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 2008;62:1006-15.
• 27 Gondim JA, Almeida JP, Albuquerque LA, Schops M, Gomes E, Ferraz T, et al. Endoscopic endonasal approach for pituitary adenoma: Surgical complications in 301 patients. Pituitary 2011;14:174-83.
• 28 Mamelak AN, Carmichael J, Bonert VH, Cooper O, Melmed S. Single-surgeon fully endoscopic endonasal transsphenoidal surgery: Outcomes in three-hundred consecutive cases. Pituitary 2013;16:393-401.
• 29 Wang F, Zhou T, Wei S, Meng X, Zhang J, Hou Y, et al. Endoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomas. Surg Endosc 2015;29:1270-80.
• 30 Zhan R, Ma Z, Wang D, Li X. Pure endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary adenomas in the elderly: Surgical outcomes and complications in 158 patients. World Neurosurg 2015;84:1572-8.
• 31 Jang JH, Kim KH, Lee YM, Kim JS, Kim YZ. Surgical results of pure endoscopic endonasal transsphenoidal surgery for 331 pituitary adenomas: A 15-year experience from a single institution. World Neurosurg 2016;96:545-55.
• 32 Yildirim AE, Sahinoglu M, Ekici I, Cagil E, Karaoglu D, Celik H, et al. Nonfunctioning pituitary adenomas are really clinically nonfunctioning? Clinical and endocrinological symptoms and outcomes with endoscopic endonasal treatment. World Neurosurg 2016;85:185-92.
• 33 Przybylowski CJ, Dallapiazza RF, Williams BJ, Pomeraniec IJ, Xu Z, Payne SC, et al. Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: Matched cohort study. J Neurosurg 2017;126:889-96.

Publication History

Article published online:
09 September 2022